Posts tagged with ‘Research ethics’
Last week, the International Committee of Medical Journal Editors issued a new policy for the transparent disclosure of conflicts of interest for the authors of papers published by journals in the consortium. A coalition of advocates have been pushing for the adoption of a uniform COI policy for medical journals since 2007, according to Merrill [...]
Researchers running clinical trials are required to submit information to the NIH-run ClinicalTrials.gov database. But two recent reports indicate that compliance with this transparency mandate is spotty at best for trials that lead to published biomedical research. What’s more, many registered trials never lead to published studies, resulting in selective publication and outcome reporting that [...]
The ethics of data selection, the potential conflicts of peer review, the “soft money lifestyle” of grant recipients, and other issues facing researchers.
Conflicts of interest are a special concern in biomedical research because they have the potential to influence the outcome of study results or clinical trials, leading to results that favor certain products or unnecessary risks for patients. New rules may curb the undue influence.
A flood of grant applications for Recovery Act funds, a heap of comments on the proposed stem cell policy, and feedback on how to manage conflicts of interest among researchers—here’s a look at some of the key numbers related to the big policy stories at the National Institutes of Health:
20,894: The total number of Challenge [...]
Managing financial conflicts of interest is a complicated policy matter, as researchers and their institutions often receive both public and private funding to support research that leads to new treatments. But research also indicates these conflicts are widespread and ingrained. How far should we go in addressing the issue?
Conflicts of interest in the realm of biomedical research are nothing new. In 1984, a study found that half of the surveyed biotech companies provided financial support for university research. But as Institute of Medicine President Harvey Fineberg said yesterday morning, this old problem “seems to be coming forth with increasing force and frequency.”
Fineberg was [...]
The U.S. Food and Drug Administration recently decided to no longer hold pharmaceutical companies to the standards of the World Medical Association’s Declaration of Helsinki while conducting human drug trials. The change poses bioethical dilemmas when U.S. companies conduct trials on foreign soil. Merrill Goozner is currently reporting from Russia, which could become “ground zero” for discussion about the shift in policy.
The University of Virginia is being accused of encouraging doctors to prescribe Johnson & Johnson’s anti-seizure and migraine drug Topamax “off-label” to treat alcoholism. But is the medicine safe for treating alcoholics without FDA approval?
Jonathan Moreno tells Nature podcast host Kerri Smith about what happens when neuroscience meets warfare. Be prepared for soldiers who don’t need sleep and detainees who can be chemically induced to trust their captors.
